CEO

Takao Ohki, M.D., Ph.D.

Professor of Vascular Surgery, The Jikei University School of Medicine

A globally recognized leader in vascular and endovascular surgery with an outstanding track record in the development and clinical evaluation of innovative medical devices.

Conducted pioneering research and development on early stent graft technologies at Albert Einstein College of Medicine in the United States. Served on advisory boards for leading medical device companies, including Cook Medical, W. L. Gore & Associates, and Terumo, contributing to the development of a wide range of stent graft technologies.

Successfully commercialized a medical device startup in the United States as both an inventor and founding member.

【Key Responsibilities】

Research and development strategy

Business and commercialization planning

Preclinical evaluation, including animal studies and simulated-use testing

Prototype evaluation and optimization

Clinical trial planning and execution

COO

​Kentaro Shima

Brings extensive experience across sales, business planning, finance, investor relations (IR), and business development, gained through roles at Shionogi & Co., Ltd., Oncolys BioPharma Inc., and a leading Japanese CDMO. Specializes in the healthcare sector, leading the development and execution of business strategies and fundraising initiatives from planning through implementation.

Previously worked at a Japanese consulting firm, advising publicly listed companies on key management issues, including mid-term business planning, shareholder activism response, capital strategy, and ESG strategy.

【Qualifications】

Licensed Pharmacist

Master of Business Administration (MBA)

​

【Key Responsibilities】

Oversees Corporate Administration

Company-wide Business Planning and Execution

​​​​​

​​

​

​

CTO

​Satoshi　Shimizu

Brings 32 years of experience in the medical device industry with Canon Inc. and Canon USA, where he led the development of innovative medical imaging systems, including X-ray imaging systems and retinal fundus cameras.

Contributed to the successful commercialization of groundbreaking technologies, including the world's first ImageChecker® computer-aided detection (CAD) system for breast cancer screening and digital mobile X-ray systems.

At Sanamedi Inc., led product development for a scoliosis diagnostic system and the RIBS Stent Graft System.

​​​​

​

​

​

​​【Key Responsibilities】

Research & Development Leadership

Development Planning and Execution

Intellectual Property Strategy

Development and Manufacturing Infrastructure

Preclinical Studies

​

​

​​​​

​​​​​​

Outside Director

Terumitsu Hasebe

CEO, Diamond Medino Capital
Professor, School of Medicine, Tokai University
Visiting Professor, Keio University School of Medicine
Visiting Professor, MIT / Harvard University

M.D., Ph.D. in Medicine, Ph.D. in Engineering

Founded the Hasebe Research Group, a medical-engineering collaboration team at the Faculty of Science and Technology, Keio University. While practicing as a physician, he earned a Ph.D. in Engineering and has been actively involved in medical device development in collaboration with various medical device manufacturers.

As one example of his work in medical device development, he was responsible for all preclinical studies required for regulatory approval of Biomedical Solutions’ cerebral thrombus retrieval stent, which was launched in 2019 and continues to be recognized as a device that helps save many patients.

In his most recent project, his team is developing the world’s first peripheral vascular stent delivery system for below-the-knee applications.

Outside Director

Takahiro Uchida

Chief Executive Officer, Sanamedi Inc.

Completed executive education programs at the Harvard T.H. Chan School of Public Health and Harvard Business School.

Board-Certified Cardiologist

Following his service as a Medical Device Reviewer at the U.S. Food and Drug Administration (FDA), he served as a Director at Boston Scientific, one of the world's leading medical device companies.

In 2012, he founded the Japan Medical Device Development Organization, the predecessor of Sanamedi Inc., with the mission of accelerating the development and commercialization of innovative medical technologies.

​